Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes.

被引：0
|
作者：
Romano, F [1 ]
Mammarella, S [1 ]
Di Valerio, A [1 ]
Creati, B [1 ]
Esposito, DL [1 ]
Vitullo, P [1 ]
Palmirotta, R [1 ]
Della Loggia, F [1 ]
Volpe, G [1 ]
Capani, F [1 ]
Battista, P [1 ]
Mariani-Costantini, R [1 ]
Cama, A [1 ]
机构：
[1] Univ G DAnnunzio, Chieti, Italy
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
203
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [21] Metabolic effects of the G1y1057Asp polymorphism in IRS-2 and interactions with obesity.
    Stefan, N
    Kovacs, P
    Stumvoll, M
    Hanson, R
    Lehn-Stefan, A
    Permana, P
    Baier, L
    Tataranni, P
    Silver, K
    Bogardus, C
    DIABETES, 2003, 52 : A256 - A256
  • [22] The strange case of G972R IRS-1 variant and diabetes. Do type 1 and type 2 diabetes share common genes?
    Federici, M
    MOLECULAR GENETICS AND METABOLISM, 2004, 81 (04) : 261 - 262
  • [23] The haplotypes of the IRS-2 gene affect insulin sensitivity in Japanese patients with type 2 diabetes
    Okazawa, K
    Yoshimasa, Y
    Miyamoto, Y
    Takahashi-Yasuno, A
    Miyawaki, T
    Masuzaki, H
    Hayashi, T
    Hosoda, K
    Inoue, G
    Nakao, K
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (01) : 39 - 48
  • [24] Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease
    Shivani Vats
    Kawaljit K. Matharoo
    Ajinder P. Singh
    A. J. S. Bhanwer
    Vasudha Sambyal
    International Journal of Diabetes in Developing Countries, 2013, 33 : 192 - 201
  • [25] Polymorphisms of IRS-2 in Italian patients with type 2 diabetes and their relation with insulin secretion and sensitivity
    D'Alfonso, R
    Ricasoli, C
    Sorge, R
    Marini, MA
    Mariani, LM
    Porzio, O
    Lauro, D
    Federici, M
    Sesti, G
    DIABETES, 2001, 50 : A238 - A238
  • [26] Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease
    Vats, Shivani
    Matharoo, Kawaljit K.
    Singh, Ajinder P.
    Bhanwer, A. J. S.
    Sambyal, Vasudha
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2013, 33 (04) : 192 - 201
  • [27] Lack of pharmacokinetic interaction between vildagliptin and metformin in patients with type 2 diabetes.
    He, YL
    Sabo, R
    Picard, F
    Wang, Y
    Campestrini, J
    Herron, J
    Ligueros-Saylan, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P62 - P62
  • [28] Association of IRS-1 and IRS-2 polymorphisms with predisposition to type-2 diabetes (T2D): a meta-analysis and trial sequential analysis
    Luo, Qiaoyan
    Ling, Zhifa
    Huang, Xiaojia
    Zuo, Ying
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2023, 42 (11): : 837 - 851
  • [29] From pathogenesis to therapeutic of type 2 diabetes. The GK rat paradigm
    Portha, Bernard
    ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA, 2007, 73 (03): : 763 - 784
  • [30] The role of PPAR γ and its related genes on the pathogenesis of type 2 diabetes.
    Hara, K
    Yamauchi, T
    Tobe, K
    Nagai, R
    Kadowaki, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 61P - 61P
12345